Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R FABRE

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Bulletin De L'Academie De Medecine|October 29, 2010
Report relating to the inclusion in Table C of phenyl-1-amino-2-propane or phenylisopropylamine and orthoxyquinoline sulfateR FABRE
Soins. Cardiologie|March 1, 1984
[Pathological anatomy and etiology of diseases of the aortic orifice]R Fabre
Bulletin De L'Academie De Medecine|March 19, 2010
Concerning the authorization to operate the La Valette source, in Euzet-les-Bains (Gard)R FABRE
Le Chirurgien-Dentiste De France|December 23, 1976
[Robert Fabre: an interview]R Fabre
Bulletin De L'Academie De Medecine|October 29, 2010
On the entry in Table C of folliculin and synthetic estrogensR FABRE
Bulletin De L'Academie De Medecine|October 29, 2010
Report on the current state of the pharmaceutical supplyR FABRE
Bulletin De L'Academie De Medecine|October 29, 2010
Report relating to the inclusion in Table A of the ethyl ester of l-methyl-4-phenylpiperine-4-carbonic acid (dolosal) and its saltsR FABRE
Bulletin De L'Academie De Medecine|October 29, 2010
Report relating to the reinstatement of the diploma of herbalist and to the reinstatement of the rules of distribution of the five plantsR FABRE
Le Progres Medical|October 29, 2010
Sulfonamides, anti sulfonamides, sulfonamide distanceR FABRE
Soins. Cardiologie|April 1, 1984
[Medical monitoring and social rehabilitation of the surgical patient]R Fabre
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Bulletin De L'Academie De Medecine|October 29, 2010
Report relating to the inclusion in Table C of phenyl-1-amino-2-propane or phenylisopropylamine and orthoxyquinoline sulfateR FABRE
Soins. Cardiologie|March 1, 1984
[Pathological anatomy and etiology of diseases of the aortic orifice]R Fabre
Bulletin De L'Academie De Medecine|March 19, 2010
Concerning the authorization to operate the La Valette source, in Euzet-les-Bains (Gard)R FABRE
Le Chirurgien-Dentiste De France|December 23, 1976
[Robert Fabre: an interview]R Fabre
Bulletin De L'Academie De Medecine|October 29, 2010
On the entry in Table C of folliculin and synthetic estrogensR FABRE
Bulletin De L'Academie De Medecine|October 29, 2010
Report on the current state of the pharmaceutical supplyR FABRE
Bulletin De L'Academie De Medecine|October 29, 2010
Report relating to the inclusion in Table A of the ethyl ester of l-methyl-4-phenylpiperine-4-carbonic acid (dolosal) and its saltsR FABRE
Bulletin De L'Academie De Medecine|October 29, 2010
Report relating to the reinstatement of the diploma of herbalist and to the reinstatement of the rules of distribution of the five plantsR FABRE
Le Progres Medical|October 29, 2010
Sulfonamides, anti sulfonamides, sulfonamide distanceR FABRE
Soins. Cardiologie|April 1, 1984
[Medical monitoring and social rehabilitation of the surgical patient]R Fabre
Pageof 9